We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — A novel combination of elsubrutinib and ...

Please provide your email address to receive an email when new articles are posted on . Overall, 56% of participants had a lupus nephritis class change on repeat biopsy. Of patients with initial ...

An investigational Toll-like receptor (TLR) antagonist was effective in reducing biomarkers and clinical symptoms of systemic lupus erythematosus (SLE) in a pilot trial, evidence that the innate ...

In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA), a common pattern of kidney damage often seen in kidney ...

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) — the most common form of the chronic autoimmune disease lupus. A ...

In a cross-sectional study, insulin growth factor binding protein 2 (IFGBP-2) showed promise as a prognosis biomarker for renal disease in pediatric lupus nephritis (LN). Serum insulin growth factor ...

CHICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have severe cardiac abnormalities such as heart enlargement, valvulopathy, and ...

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune disease lupus. A ...

A team of researchers at Vanderbilt University Medical Center (VUMC) reports that blocking an iron uptake receptor reduces disease pathology and promotes the activity of anti-inflammatory regulatory T ...